3rd Glycobiology World Congress

Glycobiology-2017 takes this pride moment to declare the 3rd Glycobiology World Congress, to be held during June 26-28, 2017 in London, UK with the theme “Glycobiology: Simple construction of sweet glycoprobes”.

The conference includes essential topics on Glycobiology, Glycans in Drug Design, Glyco Bioinformatics, Glyco Proteomics, Glyco Immunology, Glyco Biomarkers, Genomics and Metabolomics, Glycobiology and Biotechnology, Glycans in Diseases and Therapeutics, Glycans in Genetic Disorders, Structural Biology, Glycobiology in Personalized Medicine, Glycobiology in vaccine development and many more.

Glycobiology is the study of the structure, biosynthesis, and biology of saccharides (sugar chains or glycans) that are widely distributed in nature. Sugars or saccharides are essential components of all living things and aspects of the various roles they play in biology are researched in various medical, biochemical and biotechnological fields. Global glycobiology market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019).

Glycobiology conference focuses on the current research and developments in various areas of glycobiology and its related fields. The meeting engrossed a vicinity of latest discussions on novel subjects like 3-D structure determination, drug sequencing, computational approaches in glyco biology, signalling biology, glyco-biology databases, molecular modelling and simulation, drug designing, frontiers in glyco biology and recent advances in glyco biology. The three days event implanted a firm relation of upcoming strategies in the field of glycobiology with the scientific fraternity. The conceptual and applicable knowledge shared will also foster organizational collaborations to nurture scientific accelerations.

The field of glycobiology has moved rapidly with the advancement of research. Antibiotic and vaccine development and renewable bio-energy are major drivers of new research and applications. Technical advances have occurred especially in mass spectrometry, glycomics, NMR and labelling and imaging technologies. Biomedical and basic fundamental researches into glycolytic enzymes, metabolism, prebiotic oligosaccharides, plant and microbial cell walls have highlighted the importance of glycobiology to the commercially important businesses of biotechnology and medicine.


Contact Details

Company Name: Conference Series LLC
Issued By: Stephen Bruce
Phone: 16502689744
Address: 57 Ullswater Avenue, West End, Southampton Hampshire, SO18 3QS
City: Hampshire
State: Southampton
Zip: SO18 3QS
Country: United Kingdom
Website: Visit the website

Keywords : Glycobiology,

by Stephen Bruce (few months ago!)

Latest Press Releases

Text My Main Number Announced Major Shift of US Businesses toward Landline Texting

Global Department Stores Retailing 2015-2020: Ken Research

Global M-Health Device Market : Latest Research

Global Zinc Selenide Market Professional Survey Report 2017 to its Products Forecast – RAIN G..

Diesel Fuel Injection Systems 2017 Development, Trends, Share, Growth, Research and Market An..

Global Soil Testing, Inspection, and Certification Market Size, Status – ALS Ltd, Assure Qual..

Silicon Carbide Ceramics 2017 Annual Growth Value, Market Trends, Developments & Opportunities

5.1% CAGR Anticipated for Demineralized Whey Powder Ingredient Market During 2017-2027

Acoustic Wall Panels Market Forecasts, Size, Share, Regional Outlook 2017 to 2022

Rehm goes India

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.